SCHEMBL13763441

SCHEMBL13763441

CCc1ccc(N(CC(=O)OC)C(C)=O)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.45
MLYCD O95822 3/20 0.43
TDP1 Q9NUW8 1/20 0.41
PLK1 P53350 1/20 0.39
TSPO P30536 1/20 0.38
SMN1; SMN2 Q16637 4/20 0.38
HPGD P15428 2/20 0.38
TSHR P16473 2/20 0.38
HSD17B10 Q99714 2/20 0.38
PTPN1 P18031 1/20 0.37
PTPN6 P29350 1/20 0.37
PTPN11 Q06124 1/20 0.37
KDM4E B2RXH2 1/20 0.37
NPC1 O15118 1/20 0.37
GAA P10253 1/20 0.37
MAPK1 P28482 1/20 0.37
LMNA P02545 1/20 0.37
HTT P42858 1/20 0.37
CYP4F2 P78329 1/20 0.37
CYP4A11 Q02928 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5813341 0.83 MLYCD (0.45) ALDH1A1MLYCDSMN1; SMN2TSHRKDM4E
SCHEMBL11155479 0.82 MMP2 (0.49) ALDH1A1MLYCDTDP1SMN1; SMN2HSD17B10
SCHEMBL13763795 0.81 ALDH1A1 (0.46) ALDH1A1MLYCDTSHR
SCHEMBL5353769 0.81 ALDH1A1 (0.51) ALDH1A1MLYCDTSPOSMN1; SMN2TSHR
SCHEMBL10175567 0.80 ALDH1A1 (0.42) ALDH1A1TDP1PLK1SMN1; SMN2HPGD
SCHEMBL13757710 0.79 MLYCD (0.51) ALDH1A1MLYCDTDP1SMN1; SMN2HSD17B10
SCHEMBL6908944 0.79 ALDH1A1 (0.46) ALDH1A1MLYCDSMN1; SMN2TSHRHSD17B10
SCHEMBL10541028 0.77 MLYCD (0.49) ALDH1A1MLYCDSMN1; SMN2TSHRGAA
SCHEMBL6907182 0.76 PTPN1 (0.41) ALDH1A1MLYCDTDP1TSPOSMN1; SMN2
SCHEMBL10540452 0.74 MLYCD (0.46) ALDH1A1MLYCDSMN1; SMN2TSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090203676-A1 G-protein Coupled Receptor Agonists PROSIDION LIMITED (GB) 2009-08-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203676-A1 G-protein Coupled Receptor Agonists GPR119, GCGR, GPBAR1 ALDH1A1 1188/4885MLYCD 1982/4885TDP1 4607/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.